News from us and our partners

Tags

Topics

0 results

News
16 December, 2019
MedDay Reports Last Patient Study Visit in Phase 3 Clinical Trial with MD1003®*, an Important Step Towards Completion of the SPI2 Study in Progressive Multiple Sclerosis
News
22 November, 2019
Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock
News
21 November, 2019
TISSIUM Closes €39M Series B Funding Round
News
8 November, 2019
Avantium nominates Edwin Moses as Chairman of its Supervisory Board
News
17 October, 2019
Sofinnova Partners raises €333 million capital IX early-stage healthcare fund
News
16 October, 2019
ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares
News
10 October, 2019
iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board Apollon Papadimitriou, Ph.D., Named Chief Executive Officer; Marcus Irsfeld Appointed as Chief Financial Officer
News
7 October, 2019
Micropep Technologies Strengthens Its Management Team by Appointing Dr. Mikael Courbot as Chief Technical Officer
News
12 September, 2019
Inotrem announces €39 Million Series B Financing to Develop First- In-Class Immunology Therapeutics
News
23 August, 2019
HotSpot Therapeutics acquires Macroceutics to expand DEL platform
News
12 August, 2019
AgroSavfe raises €35 million in Series C financing
News
12 August, 2019
Sofinnova Partners Announces the Sale of Breath Therapeutics to Zambon
News
19 July, 2019
AgroSavfe appoints Patrice Sellès as new Chief Executive Officer and further strengthens leadership team
News
18 July, 2019
Labiotech.eu - The Business of Biotech: What to Do When the S*#t Hits the Fan - Antoine Papiernik
News
16 July, 2019
Comet Bio Completes Equity Financing and Opens U.S. Headquarters in Chicagoland Area
News
16 July, 2019
ABIVAX Completes €12 Million Capital Raise Entirely Subscribed by Sofinnova Partners at Market Price

MedDay Reports Last Patient Study Visit in Phase 3 Clinical Trial with MD1003®*, an Important Step Towards Completion of the SPI2 Study in Progressive Multiple Sclerosis

Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock

TISSIUM Closes €39M Series B Funding Round

Avantium nominates Edwin Moses as Chairman of its Supervisory Board

Sofinnova Partners raises €333 million capital IX early-stage healthcare fund

ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares

iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board Apollon Papadimitriou, Ph.D., Named Chief Executive Officer; Marcus Irsfeld Appointed as Chief Financial Officer

Micropep Technologies Strengthens Its Management Team by Appointing Dr. Mikael Courbot as Chief Technical Officer

Inotrem announces €39 Million Series B Financing to Develop First- In-Class Immunology Therapeutics

HotSpot Therapeutics acquires Macroceutics to expand DEL platform

AgroSavfe raises €35 million in Series C financing

Sofinnova Partners Announces the Sale of Breath Therapeutics to Zambon

AgroSavfe appoints Patrice Sellès as new Chief Executive Officer and further strengthens leadership team

Labiotech.eu - The Business of Biotech: What to Do When the S*#t Hits the Fan - Antoine Papiernik

Comet Bio Completes Equity Financing and Opens U.S. Headquarters in Chicagoland Area

ABIVAX Completes €12 Million Capital Raise Entirely Subscribed by Sofinnova Partners at Market Price